Shire PLC (SHPG.OQ)
15 Dec 2017
ZURICH Roche's patent dispute with London-listed Shire over the Swiss drugmaker's new haemophilia drug Hemlibra has escalated, with Shire filing a new motion in a U.S. court that Roche says aims to stop some patients from getting its medicine.
ZURICH, Dec 16 Roche's patent dispute with London-listed Shire over the Swiss drugmaker's new haemophilia drug Hemlibra has escalated, with Shire filing a new motion in a U.S. court that Roche says aims to stop some patients from getting its medicine.
* SHIRE PLC SAYS NEW FORMULATION OF ONCASPAR RECEIVES MARKETING AUTHORIZATION IN EUROPE FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
* SHIRE PLC SAYS JOHN MILLER TO SERVE AS INTERIM CFO WITH EFFECT FROM JAN 1, 2018 UNTIL THOMAS DITTRICH COMMENCES HIS EMPLOYMENT WITH CO - SEC FILING
LONDON Whitbread shares jumped more than 7 percent on Wednesday after U.S.-based hedge fund Sachem Head Capital Management declared a 3.4 percent stake in the British hotel and coffee chain operator.
Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.
Dec 5 Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.
BRIEF-Shire And Rani Therapeutics enter into collaboration to evaluate use of the Rani Pill technology
* SHIRE AND RANI THERAPEUTICS ENTER INTO COLLABORATION TO EVALUATE USE OF THE RANI PILL(TM) TECHNOLOGY FOR THE ORAL DELIVERY OF FACTOR THERAPY
LONDON Britain's top share index recovered from earlier losses to inch higher at the start of the week as cyclical sectors made a comeback, though the UK market lagged European benchmarks and Shire was a loser among health stocks.
* Mediclinic, Spire shares fall after takeover talks fall through
|Novartis AG (NOVN.S)||CHF83.80||-0.05|
|Eli Lilly and Co (LLY.N)||$86.54||+0.04|
|Catalyst Biosciences Inc (CBIO.OQ)||$10.49||+0.56|
|Abbott Laboratories (ABT.N)||$55.50||+0.77|
|Actelion Ltd (ATLN.S)||--||--|
|Supernus Pharmaceuticals Inc (SUPN.OQ)||$39.65||+1.05|
|Salix Pharmaceuticals, Ltd. (SLXP.OQ)||--||--|
|ARYx Therapeutics, Inc. (ARYX.PK)||$0.00||0.00|
|Innoviva Inc (INVA.OQ)||$13.43||+0.15|
|Sucampo Pharmaceuticals, Inc. (SCMP.OQ)||$17.00||+0.25|
Earnings vs. Estimates
- Now is the perfect time to buy these 3 healthcare stocks!
- 2 'must-have' healthcare stocks after today's updates?
- Simply the best growth stocks in the FTSE 100?
- Are these 3 Brexit beaters set to fly after today's news?
- Are these 3 stocks due for a serious price correction?
- Should you buy Shire plc, Marks and Spencer Group plc and Amec Foster Wheeler plc following today's news?